Severity of COPD - A broader prognostic assessment is necessary;Schweregrade der COPD: Die beurteilung sollte umfassender werden

Praxis

Volumn 96, Issue 48, 2007, Pages 1901-1905

  Puhan, M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

COPD; Prognosis; Severity of disease; Systemic manifestations

Indexed keywords

EID: 36849021738     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/1661-8157.96.48.1901     Document Type: Review

References (22)

1. Global Initiative for Chronic Obstructive Pulmonary Disease - GOLD workshop report, 2004. www.goldcopd.com
2. Russi EW, Leuenberger P, Brandli O, Frey JG, Grebski E, Gugger M, et al. Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society. 2002;132(5-6):67-78. (Pubitemid 34311008)
3. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142(4):233-9. (Pubitemid 40216240)
4. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2(4):367-70; discussion 371-2.
5. Christakis NA. The ellipsis of prognosis in modern medical thought. Soc Sci Med 1997;44(3):301-15. (Pubitemid 27032449)
6. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-46. (Pubitemid 38807371)
7. Schunemann HJ, Goldstein R, Mador MJ, McKim D, Stahl E, Puhan M, et al. A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J 2005;25(1):31-40. (Pubitemid 40207728)
8. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir. Crit Care Med 1995;152(6 Pt 1):2021-2031.
9. Puhan MA, Busching G, Schunemann HJ, VanOort E, Zaugg C, Frey M. Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2006;145(11):816-25. (Pubitemid 351650335)
10. Celli BR, Cote CG, Marin JM, Casanova C, Montes dO, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. The New England Journal of Medicine 2004;350(10):1005-1012. (Pubitemid 38269277)
11. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-6. (Pubitemid 29296676)
12. Camarri B, Eastwood PR, Cecins NM, Thompson PJ, Jenkins S. Six minute walk distance in healthy subjects aged 55-75 years. Respir Med 2006;100(4):658-65. (Pubitemid 43285753)
13. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am. J Respir Crit Care Med 2005;171(9):972-977. (Pubitemid 40616945)
14. Zock JP, Sunyer J, Kogevinas M, Kromhout H, Burney P, Anto JM. Occupation, chronic bronchitis, and lung function in young adults. An international study. Am J Respir Crit Care Med 2001;163(7):1572-7. (Pubitemid 32578758)
15. Schikowski T, Sugiri D, Ranft U, Gehring U, Heinrich J, Wichmann HE, et al. Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res 2005;6:152.
16. Tzortzaki ES, NM. Genetic susceptibility to chronic obstructive pulmonary disease. In: Siafakas N, editor. Management of Chronic Obstructive Pulmonary Disease: European Respiratory Society, 2006.
17. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Anto JM. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). 2000;16(6):1037-1042.
18. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003;58(2):100-105. (Pubitemid 36182995)
19. Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, et al. Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone-Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease: A Randomized Trial. Ann Intern Med 2007.
20. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Archives of Internal Medicine 2003;163(5):585-591. (Pubitemid 36314346)
21. Gadoury MA, Schwartzman K, Rouleau M, Maltais F, Julien M, Beaupre A, et al. Self-management reduces both short- and long-term hospitalisation in COPD. Eur Respir J 2005;26(5):853-7. (Pubitemid 41632042)
22. Puhan MA, Scharplatz M, Troosters T, Steurer J. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality - a systematic review. Respiratory Research 2005;6(1):54.